Prot# GS-US-384-1943: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

Project: Research project

Project Details

StatusFinished
Effective start/end date4/18/172/13/20

Funding

  • PRA Health Sciences (GS-US-384-1943)
  • Gilead Sciences, Inc. (GS-US-384-1943)